As a science-driven company that focuses on science-driven technologies, Burst Biologics is committed to providing state of the art cellular and a-cellular allografts. Every product that we process is carefully analyzed in our federally registered tissue bank. Burst Biologics does not release tissue from our laboratory unless it meets our rigorous release criteria.
The Progenokine proprietary processing technique incorporates unique breakthroughs in cryoprotection exclusive to Burst Biologics. From donor collection to final package, Burst Biologics sets the standard for the future in spine biologics and regenerative medicine. Subscribe to our blog to learn more about the latest developments in biologic technology.